Systolic heart failure treatment with the if inhibitor ivabradine trial

Real-world heart failure treatment in 10.330 patients with chronic heart failure in the netherlands

Clinical profiles, management and outcome of acute heart failure in Korea: results from the Korean acute heart failure registry (KorAHF)

Non-invasive lung impedance-guided preemptive treatment in chronic heart failure patients: a randomized controlled trial (IMPEDANCE-HF Trial)

Single dose, purified biocompatible vegf a mrna administered one week post myocardial infarction in pigs inhibits cardiac fibrosis and leads to chronic reversal of global ventricular dysfunction

The effect of oral iron therapy on functional capacity of heart failure patients with iron deficiency anemia

Dapagliflozin is associated with lower risk of hospitalization for heart failure, major adverse cardiovascular events and all-cause death compared to DPP-4i in T2D patients: CVD-REAL Nordic

Total events of hospitalization for heart failure in new users of sglt-2 inhibitors vs other glucose lowering drugs - real world data from 3 countries and more than 45,000 patients: the CVD-REA study

A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment with Subcutaneous Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Preserved Ejection Fraction: Rationale and d